FULGENT GENETICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FULGENT GENETICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $2.00K.
- FULGENT GENETICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $9.00K.
- FULGENT GENETICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $3.00K, a 0.00% change year-over-year.
- FULGENT GENETICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $3.00K, a 87.50% decline year-over-year.
- FULGENT GENETICS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $1.00K, a 98.04% decline from fiscal 2024.
- FULGENT GENETICS, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $51.00K, a 1600.00% increase from fiscal 2023.
- FULGENT GENETICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $3.00K, a 90.32% decline from fiscal 2022.
- FULGENT GENETICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $31.00K, a 63.95% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $9.00K 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $1.00K 10-K · filed 2026-02-27 | |
| 2024-12-31 | $51.00K 10-K · filed 2026-02-27 | |
| 2023-12-31 | $3.00K 10-K · filed 2026-02-27 | |
| 2023-06-30 | $3.00K 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $31.00K 10-K · filed 2025-02-28 | |
| 2022-06-30 | $3.00K 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $16.00K 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $86.00K 10-K · filed 2024-02-28 | |
| 2021-09-30 | $17.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $24.00K 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $44.00K 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $104.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $62.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $28.00K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $12.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $38.00K 10-K · filed 2022-02-28 | |
| 2019-09-30 | $16.00K 10-Q · filed 2020-11-09 | $30.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $5.00K 10-Q · filed 2020-11-09 | $15.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-03-31 | $4.00K 10-Q · filed 2020-11-09 | $17.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2018-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $15.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $1.00K 10-Q · filed 2019-11-08 | $14.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $7.00K 10-Q · filed 2019-11-08 | $17.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-03-31 | $2.00K 10-Q · filed 2019-11-08 | $31.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2017-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $31.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | |
| 2017-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | |
| 2017-03-31 | $2.00K 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |